Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma

NCT01120275 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT01120275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01120275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Terminated
Start date
October 31, 2010
Completion date
August 31, 2015
Enrollment
36 (actual)
Sites
178

Conditions

As the registry lists them; a condition with its own page is linked.

acral lentiginous malignant melanoma, lentigo maligna malignant melanoma, nodular malignant melanoma, recurrent melanoma, solar radiation-related skin melanoma, stage iv melanoma, superficial spreading malignant melanoma